AMGEVITA is a drug that inhibits the inflammatory process in different inflammation diseases. The active ingredient, adalimumab, is a human monoclonal antibody produced by cultured cells. Monoclonal antibodies are proteins that recognize and bind to other unique proteins. Adalimumab binds to a specific protein (tumor necrosis factor or TNFα), which is present to an increased extent in various inflammatory diseases.
Your physician may prescribe AMGEVITA for the treatment of inflammatory diseases such as rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, ankylopoetics spondylitis, axial spondylarthritis without radiographic evidence of spondylitis ankylopoetica, arthritis psoriatica, psoriasis, hidradenitis suppurativa, Crohn's disease, ulcerative colitis and non-infectious uveitis affecting the back of the eye.